Headlands Research, a clinical trial site network with locations across the U.S. and Canada, has made its first step into the ...

The move helps in expediting the enrolment process for central nervous system, vaccine, as well as specialty trials.

Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of CMRCenter ...

CMRC’s leadership team includes investigators such as Carmen C. Deseda, and the site brings decades of clinical trials and ...

SAN FRANCISCO--(BUSINESS WIRE)--Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of Clinvest Research, an established site based in ...

--Headlands Research, a global next-generation clinical research site organization, today announced its acquisition of Summit Research Network in Portland, Oregon. Coupled with the new acquisition ...

SAN FRANCISCO, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Headlands Research, a KKR-backed next-generation site organization seeking to profoundly impact the clinical trial landscape, today announced that ...

SAN FRANCISCO--(BUSINESS WIRE)--Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of AMCR Institute, which has been in operation for more ...

Headlands Research now includes 18 sites across the United States and Canada. The addition of Pharmasite Research follows the acquisition or creation of five new sites in 2023.

San Francisco-based Headlands has already carried out more than 5,000 clinical trials across its growing platform of 15 network research sites in the U.S. and Canada.

SAN FRANCISCO, May 13, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced its acquisition of ...